SPC511
Imetelstat eða lyfjafræðilaga viðunandi salt þar af / Imetelstat, or a pharmaceutically acceptable salt thereof
Status:
UmsóknApplication date:
5.5.2025Application published:
15.6.2025
Max expiry date:
14.11.2038Medicine name:
RyteloMedicine for children:
No
Timeline
Today
5.5.2025Application
15.6.2025Publication
14.11.2038Expires
Marketing license
IS authorization number:
EU/1/24/1894Date:
24.3.2025
Foreign authorization number:
EU/1/24/1894Date:
7.3.2025
Owner
Name:
Geron CorporationAddress:
919 E. Hillsdale Blvd., Foster City, CA 94404 US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP3456333
Deadlines
TypeDeadline until
Type: Formgallafrestur, fyrsti
Deadline until: 08.08.2025